Key points
- FY2026 revenue: $131.2 million, up 5.7%
- FY2026 normalised EBITDA: $3.0 million, down 66.3%
- FY2026 NPAT loss: $4.4 million, down 242%
- New CEO and CFO starting in FY2027
- Positive outlook for FY2027 with improved metrics
Full summary
Vitura Health Limited announced its financial results for the year ended 30 June 2026. The company reported a total revenue of $131.2 million, up 5.7% from the previous year, but faced significant challenges including margin compression and a net loss after tax of $4.4 million. The normalised EBITDA stood at $3.0 million, down 66.3% from the previous year. The company has undergone significant leadership changes, with a new CEO and CFO set to start in FY2027. Vitura has also shifted its focus to a more mature and disciplined operating model, aiming for sustainable profitability and improved shareholder value. The company is optimistic about its performance in FY2027, with most metrics ahead of budget.
Guidance
FY2027 revenue growth expected to moderate, EBITDA improvement expected
Outlook
Vitura is optimistic about FY2027, expecting improved performance and sustainable profitability.